Demo mode: simulated data, for showcase onlyDemo mode: simulated data, for showcase onlyDemo mode: simulated data, for showcase only
36%chance
Prime editing, a precise 'search and replace' gene-editing tool, is expected to reach key human milestones. Resolves YES if a peer-reviewed clinical result reports a successful prime-editing treatment in patients in 2026. Source: Nature / NEJM.
What's everyone's thesis here? I'm undecided.
Sold my position. Taking profits while I can.
What's everyone's thesis here? I'm undecided.
Adding to my position here. The odds are in our favor.
Anyone else think this is overvalued right now?
I think people are overreacting. This won't happen.
Fading this. The smart money is on the other side.
Anyone have insights on the resolution criteria?
The volume on this market has been insane lately.